Adetunji T. Toriola, MD, PhD

Associate Professor of Surgery

Education

Medical School: MD, Obafemi Awolowo University, Ile-Ife, Nigeria, 1998
DA (Diploma in Anesthesia), West African College of Surgeons, 2004

Graduate School

MPH (Master of Science in Public Health), University of Kuopio, Kuopio, Finland, 2007
PhD (Epidemiology), University of Tampere, Tampere, Finland, 2011

Post Doctoral Education

Postdoctoral Fellowship: German Cancer Research Center (DKFZ), Heidelberg, Germany, 2011-2012

Research Interests

Dr. Toriola’s research focuses on characterizing the molecular basis and determinants of mammographic breast density that are targetable, especially in premenopausal women, and to translate study findings to breast cancer prevention, through clinical trials. He is the PI on an NIH/NCI funded phase III clinical trial investigating the effect of RANKL inhibition on mammographic breast density and breast tissue/blood markers in high-risk premenopausal women with dense breasts (R37CA235602). In addition, he conducts molecular epidemiologic studies on gastrointestinal cancers (colorectal and pancreatic cancers), evaluating the use of biomarkers to investigate the associations of energetics, hormones and inflammation with cancer risk/mortality. He is especially interested in the interplay between inflammation and insulin resistance in colorectal and pancreatic cancer risk/mortality and the translational importance.

Contact Information

660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110
(314) 286-2668
a.toriola@wustl.edu

PubMed page for Dr. Toriola